Evidence map›Paper›PMID 27601084›Full record

ArticleScientific reports2016

A new autosomal dominant eye and lung syndrome linked to mutations in TIMP3 gene.

Isabelle Meunier, Béatrice Bocquet, Gilles Labesse, Christina Zeitz, Sabine Defoort-Dhellemmes, Annie Lacroux, Martine Mauget-Faysse, Isabelle Drumare, Anne-Sophie Gamez, Cyril Mathieu and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Disease-CausingInternational journal of molecular sciences · 2024
    Article
  3. The TIMP protein family: diverse roles in pathophysiology.American journal of physiology. Cell physiology · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Reflections on the evolution of the vertebrate tissue inhibitors of metalloproteinases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Review
  12. Matrix metalloproteinases in emphysema.Matrix biology : journal of the International Society for Matrix Biology · 2018
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 2 countries.

Isabelle MeunierInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Béatrice BocquetInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Gilles LabesseCenter for structural biochemistry Montpellier, INSERM U1054-CNRS UMR5048, Montpellier, France.
Christina ZeitzSorborne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, 75012 Paris. CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, 28 rue de Charenton, 75012 Paris. Institute of Ophthalmology, University College of London, London EC1V 9EL, UK.
Sabine Defoort-DhellemmesService d'Exploration de la Vision et Neuro-ophtalmologie, Hôpital Robert Salengro, CHU de Lille, France.
Annie LacrouxInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Martine Mauget-FaysseFondation Adolphe de Rothschild, 25 rue Manin, 75019 Paris.
Isabelle DrumareService d'Exploration de la Vision et Neuro-ophtalmologie, Hôpital Robert Salengro, CHU de Lille, France.
Anne-Sophie GamezDépartement de pneumologie et d'addictologie. University Hospital Arnaud de Villeneuve, Montpellier, France.
Cyril MathieuChest and Heart Imaging department, Arnaud de Villeneuve Hospital, Montpellier, France.
Virginie MarquetteInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Lola SagotInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Claire-Marie DhaenensCHU Lille, Institut de Biochimie et Biologie Moléculaire, F-59000 Lille, France.
Carl ArndtEye clinic, Hôpital Robert Debré, CHRU de Reims, France.
Patrick CarrollInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Martine Remy-JardinDepartment of Thoracic Imaging, Hospital Calmette, University Centre of Lille, France.
Salomon Yves CohenOphthalmic center for imaging and laser, rue Antoine Bourdelle, Paris - Department of Ophthalmology, Intercity Hospital and University Paris Est, Créteil, France.
José-Alain SahelSorborne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, 75012 Paris. CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, 28 rue de Charenton, 75012 Paris. Institute of Ophthalmology, University College of London, London EC1V 9EL, UK.
Bernard PuechService d'Exploration de la Vision et Neuro-ophtalmologie, Hôpital Robert Salengro, CHU de Lille, France.
Isabelle AudoSorborne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, 75012 Paris. CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DHOS CIC1423, 28 rue de Charenton, 75012 Paris. Institute of Ophthalmology, University College of London, London EC1V 9EL, UK.
Sarah MrejenFondation Adolphe de Rothschild, 25 rue Manin, 75019 Paris.
Christian P HamelInstitute for Neurosciences of Montpellier U1051, University of Montpellier-University Hospital, Genetics of Sensory Diseases, Montpellier, France.
Université de Montpellier · FRCentre Hospitalier Universitaire de Lille · FRCentre National de la Recherche Scientifique · FRFondation Ophtalmologique Adolphe de Rothschild · FRHôpital Arnaud de Villeneuve · FRCentre Hospitalier Universitaire de Reims · FRHôpital Albert Calmette · FRParis-Est Sup · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To revisit the autosomal dominant Sorsby fundus dystrophy (SFD) as a syndromic condition including late-onset pulmonary disease. We report clinical and imaging data of ten affected individuals from 2 unrelated families with SFD and carrying heterozygous TIMP3 mutations (c.572A > G, p.Y191C, exon 5, in family 1 and c.113C > G, p.S38C, exon 1, in family 2). In family 1, all SFD patients older than 50 (two generations) had also a severe emphysema, despite no history of smoking or asthma. In the preceding generation, the mother died of pulmonary emphysema and she was blind after the age of 50. Her two great-grandsons (<20 years), had abnormal Bruch Membrane thickness, a sign of eye disease. In family 2, eye and lung diseases were also associated in two generations, both occurred later, and lung disease was moderate (bronchiectasis). This is the first report of a syndromic SFD in line with the mouse model uncovering the role of TIMP3 in human lung morphogenesis and functions. The TIMP3 gene should be screened in familial pulmonary diseases with bronchiectasis, associated with a medical history of visual loss. In addition, SFD patients should be advised to avoid tobacco consumption, to practice sports, and to undergo regular pulmonary examinations.

Indexed as

Genetic Predisposition to DiseaseAgedBase SequenceFamilyFemaleFundus OculiHumansLungMacular DegenerationMaleMiddle AgedMutationPedigreeProtein Structure, SecondaryTissue Inhibitor of Metalloproteinase-3Tomography, X-Ray ComputedTIMP3 protein, humanTissue Inhibitor of Metalloproteinase-3

Identifiers

PMID27601084
PMCPMC5013278
OpenAlexW2516114686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.